How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Merck’s non-oncology diversification to cushion looming Keytruda patent cliff, reveals GlobalData

calendar_today November 5, 2026 person Sarath.Chandra@globaldata.com domain globaldata

Merck & Co’s blockbuster oncology product Keytruda (pembrolizumab), which has generated over half of the company’s total revenue in the last three years, faces key patent expirations and market rivalry from 2028. Consequently, Keytruda’s projected 2032 revenues are slated to plummet by 57% relative to 2025 performance. However, the company’s non-oncology portfolio is forecasted to […]

open_in_new Read original post